Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Holbrook › NPI 1134561194
NP / PA

Reilly, Debra

Reilly, Debra was paid $12K by Medicaid between Jan 2021 and Oct 2023, across 9 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 39% of everything it billed.

33Billing provider infoREILLY, DEBRA
HOLBROOK, NY 11741
33aNPI1134561194assigned 07/18/2013
28Total paid$12K
24GClaims363
24DCodes billed9
24AFirst – last monthJan 2021 – Oct 2023
Compared with peers

Next to other Pediatric Nurse Practitioner providers in New York

Rank by total paid#28 of 91
Median peer was paid$2K
This provider vs. median5.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$2.0K$4.0K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2021323$10K
202228$875.52
202312$780.24
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 39% 72 72 $5K
90460 Immunization administration through 18 years of age via any route, first or only component 24% 94 94 $3K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 15% 15 15 $2K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 10% 58 58 $1K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 6.7% 12 12 $780.24
92551 2.9% 32 32 $339.90
96127 1.9% 50 50 $220.08
99000 0% 13 13 $0.00
90686 0% 17 17 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.